| Literature DB >> 26497786 |
Rossella Russo1, Carlo Nucci2, Maria Tiziana Corasaniti3, Giacinto Bagetta4, Luigi Antonio Morrone4.
Abstract
Glaucoma is a neurodegenerative disease caused by the progressive apoptotic death of retinal ganglion cells (RGCs). The mechanisms leading to the RGC loss are still unknown but it is now clear that, besides elevated intraocular pressure (IOP), which is considered the main risk factor, other IOP-independent determinants are responsible for the development of the optic neuropathy. Autophagy is a highly conserved catabolic pathway by which cellular components are degraded through the lysosomes. Dysfunctional autophagic pathway has been associated with several neuropathological conditions and a considerable number of studies have proved autophagy as a potential target for pharmacological modulation to achieve neuroprotection. Here, we review the current literature bridging the degeneration of RGCs to alterations of the autophagic pathway; we also discuss the possible role of autophagy in the pathogenesis and progression of glaucoma in view of the future application of autophagy modulators for glaucoma therapy.Entities:
Keywords: Autophagy; Glaucoma; Neurodegeneration; Neuroprotection
Mesh:
Year: 2015 PMID: 26497786 DOI: 10.1016/bs.pbr.2015.04.009
Source DB: PubMed Journal: Prog Brain Res ISSN: 0079-6123 Impact factor: 2.453